Looks like most everyone has left this board. Hat
Post# of 30028
Posted On: 04/26/2015 8:51:55 PM
Looks like most everyone has left this board. Hate to see it because I really appreciated hearing from some of the posters.
I think the sale of DX division could help turn this thing around. Also, MANF for RP, from what I have been able to read, would be a nice asset for a big pharma. Either would infuse some cash and help us move forward with additional MANF indications and/or ESS. Hoping GC has another surprise up his sleeve and he drops it on us soon.
I think the sale of DX division could help turn this thing around. Also, MANF for RP, from what I have been able to read, would be a nice asset for a big pharma. Either would infuse some cash and help us move forward with additional MANF indications and/or ESS. Hoping GC has another surprise up his sleeve and he drops it on us soon.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼